Roivant Sciences Ltd.

NASDAQ: ROIV · Real-Time Price · USD
11.86
0.11 (0.94%)
At close: Aug 15, 2025, 2:32 PM

Roivant Sciences Cash Flow Statement

Financials in USD. Fiscal year is April - March.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2025 Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Net Income
-356.73M 4.23B -1.12B -924.12M
Depreciation & Amortization
14.07M 22.04M 18.86M 5.93M
Stock-Based Compensation
289.03M 199.63M 217.78M 564.96M
Other Working Capital
-58.88M -3.65M 1.99M 316K
Other Non-Cash Items
-708.77M -5.24B 29.09M -340.22M
Deferred Income Tax
n/a n/a n/a n/a
Change in Working Capital
-77.05M 19.04M 6.34M 15.72M
Operating Cash Flow
-839.45M -765.27M -843.39M -677.73M
Capital Expenditures
-4.6M -1.38M -12.69M -17.44M
Cash Acquisitions
229.36M -36.98M 107.86M -39K
Purchase of Investments
-4.06B n/a n/a n/a
Sales Maturities Of Investments
1.96B n/a n/a 320.17M
Other Investing Acitivies
110.47M 5.24B -139.43M 600K
Investing Cash Flow
-1.77B 5.2B -44.27M 303.3M
Debt Repayment
-52.75M -30.7M 129.75M 14.81M
Common Stock Repurchased
-1.29B n/a n/a n/a
Dividend Paid
n/a -6M n/a n/a
Other Financial Acitivies
13.41M 17.51M -10M 291.98M
Financial Cash Flow
-1.22B 419.36M 499.46M 306.79M
Net Cash Flow
-3.82B 4.86B -381.92M -67.64M
Free Cash Flow
-844.05M -766.65M -856.08M -695.16M